New imaging tool could help spot cancerous bone tumors earlier

NCT ID NCT04884048

Completed Diagnosis Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new structured reporting system called BTI-RADS to help doctors better assess bone tumors from X-rays, CT, and MRI scans. Researchers analyzed images from 1,100 patients to see if the tool could more accurately tell which tumors are likely cancerous. The goal is to improve diagnosis and guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this tool could help doctors more accurately identify which bone tumors are likely cancerous, leading to better and faster treatment decisions.
What could go wrong: This is a validation study, not a treatment trial. The tool may not prove more accurate than current methods, and results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone cancer bone neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE NEOPLASM

Contacts and locations

Locations

CHRU Besançon

Besançon, 25000, France
CHRU Lille

Lille, Nord, 59037, France
Centre Oscar Lambret

Lille, Nord, 59000, France
Chu Bordeaux

Bordeaux, 33000, France
Groupement des Hopitaux de l'institut catholique de Lille

Lille, Nord, 59020, France
Hôpital Universitaire Paris Centre site Cochin APHP

Paris, Ille de France, 75014, France
Hôpital de Purpan - CHU Toulouse

Toulouse, 31300, France
University hospital of Nancy

Nancy, Grand Est, 54000, France
Université Lyon 1 - Centre Hospitalier Lyon-Sud

Lyon, 69310, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.